“This is after all an eclectic commentary column and it is not required to connect all the dots. We are certainly in a time of transition, upheaval and reexamination of all those previously held beliefs concerning the structure of product and basis for the sale itself. It appears nothing was sacred, which makes sense because apparently very little of what we have been doing was working well anyway. Like so many others I am trying to understand the changes in sales emphasis and product direction. How does the expanding universe of chronic illness risk management influence my practice and prioritize my planning to best serve my distribution?
Consequently, meandering through my current understanding of what’s relevant and what’s superfluous might be fun. Some of these random thoughts have appeared before—they therefore probably bear repeating. So in no particular order of importance here goes…”
Click here to read the full article, originally published in Broker World Magazine.